Revenue +12.5% YoY, but PAT -28.2%: Margin pressure masks bullish capacity story
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guidance cut from ₹800 Cr to ₹750 Cr (6.25% lower); prior margin targets (28-29%) not in sight yet (Q2 20.8%)
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong multi-year expansion thesis (Phase-3 + order book ₹550+ Cr) is offset by Q2 profitability decline (PAT −28.2% YoY) and guidance cut (₹800 Cr → ₹750 Cr). Margin compression from freight/raw-material costs is real near-term; recovery hinges on export mix tilt + cost pass-through.
₹192.6 Cr
Revenue · +12.5% YoY₹33 Cr
Reported PAT · −28.2% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
FY27 revenue guidance of ₹800 Cr remains on track
MISSMD now says ₹750 Cr target; ₹800 Cr prior guidance is withdrawn
EBITDA margin improving from Q1 to Q2
METQ2 20.8% EBITDA margin vs Q1 16.4%; confirmed in numbers
Exports 40% domestic, 60% export in Q2
OVERSTATEDMD says 'anywhere between probably 40% to 60%' — evasive on exact mix
RAW material costs stabilizing; margin recovery likely
OVERSTATEDQ2 EBITDA margin 20.8% vs 28-29% historical; freight/logistics still elevated
Order book ₹550+ Cr covers 6+ months
METH1 revenue ₹330 Cr; H2 needs ₹500+ Cr for ₹750 Cr full-year target — executable but tight
Earnings quality
What changed since the last call
FY27 revenue guidance cut
DowngradePrior: ₹800 Cr. Now: ₹750 Cr (implicit, ~₹50 Cr or 6.25% lower). Not formally restated.
Margin trajectory delayed
DowngradeQ2 EBITDA margin 20.8% vs 28-29% prior. Freight/RM cost headwinds persist; recovery now Q3 target, not Q2.
Export recovery momentum
UpgradeU.S. tariff withdrawn Feb 2026; North America orders accelerating. Middle East crisis impact fading. Export outlook now >40%.
Phase-3 expansion on track
NeutralApril 2027 commissioning confirmed; 6,500 MVA, 220 kV entry expected 3–6 months post-live. Unchanged vs prior.
The Q&A
Analysts pressed hard on margins (freight impact in %), working capital sustainability, capacity competition, and exact export-domestic margin delta. Alay Shah was confident but evasive on percentages; Q&A tone was tense on the PAT decline vs revenue growth mismatch.
Working capital sustainability — Aadesh Gosalia, Spark Capital
AnsweredWC is normal for growth. Receivables are interest-bearing (180-day LC to customer, established after initial 60-day LC). Financial assets reflect new project investment. Not alarming given LC interest earned.
Revenue recognition timing — Aadesh Gosalia, Spark Capital
PartialPart deferred from Q1 (₹30–35 Cr), part new orders from improved market. Going forward, more than INR750 Cr quarterly run rate expected.
EBITDA margin outlook — Jiten Parmar, Aurum Edge
PartialFreight is transient; once demand grows and new capacity adds, margin to maintain high EBITDA. Cannot guarantee 30% percentage, but absolute EBITDA ₹200–225 Cr on ₹750 Cr revenue is target.
Capacity utilization & competition — Prathamesh Sawant, Abakkus Investment
AnsweredWe are exporting; others are domestic-focused. Export EBITDA much higher. Higher MVA (lower volume, higher margin) vs peers' commodity models. Margin resilience from export mix and efficiency.
U.S. market dynamics — Ravi Swaminathan, Avendus Spark
AnsweredTariff withdrawn Feb 2026; orders steadily increasing. Lead-time for higher kV is 1–1.5 years. Demand pent-up post-tariff. Supply to U.S. now 40–60% export mix likely.
Export-domestic margin spread — Het Shah, Quantum AMC
DodgedExport EBITDA margins much higher than domestic. Cannot disclose exact figures; mix of customers/products. Focus on balance in order execution.
220 kV entry strategy — Maitri, Sapphire Capital
AnsweredApprovals 3–6 months post-plant live (April 2027). Margins will remain same as current. No premium. Existing customers already verbal committed to take 220 kV once approved.
Profitability under expansion — Rahul Majethia, Eiko Quantum
PartialGrowth requires margin compression short-term. But brand + customer confidence will restore it. Demand is high; we won't be stagnant. Expansion pays off in 2-3 years.
220 kV manufacturing timeline — Mohammed Nameer, Eiko Quantum
AnsweredLower kV 3-6 months lead-time; higher kV >1 year. FY29 100% utilization planned. Phase-3 adds 6,500 MVA; total 14,000 MVA breakeven 35-40% utilization.
Raw material margin resilience — Basant Bansal, NBG Investments
PartialNot sure costs will fall. But pricing is passing through to customers now. New orders at current RM prices, so margins will improve.
FY28-29 revenue and M&A — Nirav, Individual Investor
AnsweredNot conservative. FY28 ₹1,000 Cr, FY29 ₹1,250–1,500 Cr. At 100% capacity, max ₹1,500 Cr. Exploring M&A in related segments.
Guidance
FY27 ₹750 Cr (revised down from ₹800 Cr)
MediumH1 ₹330 Cr delivered; H2 needs ₹420 Cr to hit ₹750 Cr. Order book ₹550+ Cr but execution risk remains.
FY28 ₹1,000 Cr; FY29 ₹1,250–1,500 Cr
MediumContingent on Phase-3 ramp, export recovery, 220 kV approvals. At 100% capacity, max ₹1,500 Cr.
FY27 EBITDA ₹200–225 Cr (~26.7%–30% on ₹750 Cr)
LowQ2 20.8% margin; historically 28-29%. Freight/RM cost headwinds persist; recovery depends on export tilt + cost pass-through.
FY28+ margins to improve further with higher export %, Phase-3 ramp
MediumQualitative; no specific % given. Contingent on cost stabilization and demand durability.
Phase-3 (6,500 MVA) commissioned April 2027; total capacity 14,000 MVA
HighCivil, PEB, utility work on track. Production equipment ordered. No delay flagged.
Risks the call surfaced
Margin compression
HighQ2 EBITDA 20.8% vs 28-29% historical. Freight/raw-material costs elevated. If export mix stalls, margin floor stays 20-22%.
Guidance credibility
HighFY27 guidance downgraded from ₹800 Cr to ₹750 Cr without formal restatement. Margin targets (₹200–225 Cr EBITDA) not yet on trajectory. Analysts may question guidance rigor.
Execution risk (Phase-3)
MediumPhase-3 (6,500 MVA, 220 kV) commissioning April 2027 is tight timeline. Approval for 220 kV transformer class 3-6 months post-live. If delayed, revenue ramp to ₹1,000 Cr (FY28) at risk.
Capacity oversupply risk
MediumIndustry-wide capacity expansion (Wauree, others) may pressurize pricing. Shilchar's edge is export + higher-MVA product, but oversupply could compress margins further.
Working capital cycle elongation
LowWC increased to ₹200 Cr in H1. If sales ramp without cash conversion, cash drag could stress liquidity during Phase-3 capex.
Management
Score 6/10. Transparent on operational metrics but evasive on margin specifics. Alay Shah confident on long-term thesis but vague on near-term execution. Did not formally restate downgraded FY27 guidance (₹800 Cr → ₹750 Cr). Phase-3 on track (April 2027 commissioning). Order book ₹550+ Cr validates demand. But PAT fell 28.2% YoY despite revenue growth — margin compression not fully attributed to transient costs.
1 · Q3 FY27
100% capacity utilization; export EBITDA margin inflection
2 · April 2027
Phase-3 commissioning; 220 kV approvals expected in parallel
3 · H2 FY27
Need ₹500+ Cr revenue to hit revised ₹750 Cr target
Margin compression from freight/raw-material costs is real near-term; recovery hinges on export mix tilt + cost pass-through.
Informational and educational content only. Not investment advice.